- Home
- GSBC vs ABCL Comparison
GSBC vs ABCL Comparison
Compare GSBC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- ABCL
- Stock Information
- Founded
- GSBC 1923
- ABCL 2012
- Country
- GSBC United States
- ABCL Canada
- Employees
- GSBC N/A
- ABCL N/A
- Industry
- GSBC Major Banks
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- ABCL Health Care
- Exchange
- GSBC Nasdaq
- ABCL Nasdaq
- Market Cap
- GSBC 665.7M
- ABCL 772.9M
- IPO Year
- GSBC N/A
- ABCL 2020
- Fundamental
- Price
- GSBC $55.65
- ABCL $3.41
- Analyst Decision
- GSBC Hold
- ABCL Strong Buy
- Analyst Count
- GSBC 2
- ABCL 4
- Target Price
- GSBC $59.50
- ABCL $8.33
- AVG Volume (30 Days)
- GSBC 45.2K
- ABCL 6.2M
- Earning Date
- GSBC 07-15-2025
- ABCL 08-05-2025
- Dividend Yield
- GSBC 2.88%
- ABCL N/A
- EPS Growth
- GSBC 10.52
- ABCL N/A
- EPS
- GSBC 5.60
- ABCL N/A
- Revenue
- GSBC $219,572,000.00
- ABCL $23,114,000.00
- Revenue This Year
- GSBC N/A
- ABCL N/A
- Revenue Next Year
- GSBC $1.04
- ABCL $67.99
- P/E Ratio
- GSBC $9.94
- ABCL N/A
- Revenue Growth
- GSBC N/A
- ABCL N/A
- 52 Week Low
- GSBC $47.58
- ABCL $1.89
- 52 Week High
- GSBC $68.02
- ABCL $3.68
- Technical
- Relative Strength Index (RSI)
- GSBC 44.88
- ABCL 76.76
- Support Level
- GSBC $55.11
- ABCL $3.10
- Resistance Level
- GSBC $56.55
- ABCL $3.57
- Average True Range (ATR)
- GSBC 1.20
- ABCL 0.25
- MACD
- GSBC -0.16
- ABCL 0.10
- Stochastic Oscillator
- GSBC 22.31
- ABCL 89.68
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.